Zaza, Gianluigi
 Distribuzione geografica
Continente #
EU - Europa 5.645
NA - Nord America 5.631
AS - Asia 3.754
SA - Sud America 581
AF - Africa 56
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.682
Nazione #
US - Stati Uniti d'America 5.549
GB - Regno Unito 1.468
SG - Singapore 1.415
CN - Cina 1.410
RU - Federazione Russa 1.258
IT - Italia 669
SE - Svezia 552
BR - Brasile 500
FR - Francia 478
HK - Hong Kong 371
IE - Irlanda 351
DE - Germania 349
FI - Finlandia 251
VN - Vietnam 163
KR - Corea 85
UA - Ucraina 74
IN - India 58
ID - Indonesia 43
AT - Austria 37
CA - Canada 36
BE - Belgio 33
JP - Giappone 33
AR - Argentina 31
TR - Turchia 30
MX - Messico 28
PK - Pakistan 27
PL - Polonia 22
BD - Bangladesh 21
NL - Olanda 19
ES - Italia 15
ZA - Sudafrica 15
EC - Ecuador 13
RO - Romania 12
IL - Israele 11
IQ - Iraq 11
CZ - Repubblica Ceca 10
GR - Grecia 9
UZ - Uzbekistan 9
AU - Australia 8
CL - Cile 8
PY - Paraguay 8
AZ - Azerbaigian 7
CH - Svizzera 7
MA - Marocco 7
VE - Venezuela 7
DZ - Algeria 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
DK - Danimarca 5
EG - Egitto 5
EU - Europa 5
GE - Georgia 5
LB - Libano 5
DO - Repubblica Dominicana 4
LA - Repubblica Popolare Democratica del Laos 4
MY - Malesia 4
PH - Filippine 4
SA - Arabia Saudita 4
SV - El Salvador 4
BO - Bolivia 3
HU - Ungheria 3
JO - Giordania 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
RS - Serbia 3
TG - Togo 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
CG - Congo 2
CI - Costa d'Avorio 2
HN - Honduras 2
HR - Croazia 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
ME - Montenegro 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
Totale 15.660
Città #
Southend 1.312
Chandler 876
Singapore 586
Ashburn 584
Dallas 496
Jacksonville 464
Hong Kong 368
Dublin 340
Moscow 313
Woodbridge 262
Beijing 245
Ann Arbor 235
Wilmington 155
Lawrence 150
Princeton 150
Verona 130
New York 126
Houston 102
Jinan 102
Los Angeles 92
Redmond 80
Shenyang 80
Columbus 79
The Dalles 74
Nanjing 72
Sindelfingen 66
Redondo Beach 61
Hebei 59
Dong Ket 57
Munich 57
Tianjin 56
Buffalo 55
Helsinki 52
Seattle 46
São Paulo 45
Santa Clara 43
Council Bluffs 42
Changsha 39
Taizhou 37
Milan 35
Ningbo 35
Redwood City 35
Jakarta 33
Turku 33
Brussels 32
Tokyo 32
Boardman 31
Zhengzhou 31
Haikou 30
Chicago 27
Jiaxing 27
Lancaster 27
Rome 27
Kent 26
Nanchang 26
Vienna 25
Ho Chi Minh City 24
San Francisco 24
Hangzhou 23
Nuremberg 23
Seoul 22
Guangzhou 21
Taiyuan 21
Brooklyn 19
Mianwali 17
Norwalk 16
Phoenix 16
Rio de Janeiro 16
Lanzhou 15
Warsaw 15
Bologna 14
Montreal 14
Frankfurt am Main 13
London 13
Porto Alegre 13
Atlanta 12
Bari 12
Brasília 12
Chennai 12
Denver 12
Falkenstein 12
Fuzhou 12
Hyderabad 12
Boston 11
Mexico City 11
Cambridge 10
Catanzaro 10
Fairfield 10
Hanoi 10
Padova 10
Stockholm 10
Washington 10
Toronto 9
Amsterdam 8
Ankara 8
Auburn Hills 8
Campinas 8
Dearborn 8
Johannesburg 8
Shanghai 8
Totale 9.292
Nome #
Common Variants Associated to Type 2 Diabetes in the Italian Population 430
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 213
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 204
Terapia della glomerulonefrite membrano proliferativa. 184
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 181
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 158
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 158
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 152
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 151
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 150
Identificazione del primo biomarcatore diagnostico urinario per il rene a spugna midollare (MSK): risultato di uno studio di proteomica mediante spettrometria di massa 148
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 145
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 144
mTOR inhibitors and renal allograft: Yin and Yang. 143
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 142
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 138
Abdominal-aortic atherosclerotic plaque index and perioperative outcomes in partial nephrectomy 137
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 137
Liver Metastases From Renal Oncocytoma With Vascular Extension 137
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 136
Sulodexide and glycosaminoglycans in the progression of renal disease. 135
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 135
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 134
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 134
Everolimus-associated interstitial pneumonia in a renal transplant patient: a case report 134
Histopathology and Long-Term Outcome of Kidneys Transplanted From Donors With Severe Acute Kidney Injury 133
Caratterizzazione del profilo trascrittomico nei linfomonociti periferici di trapiantati renali con rigetto cronico anticorpo-mediato (RCAM) 132
Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy 132
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 132
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 130
Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis 130
Post-renal transplant pregnancy: a project to plan carefully 128
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 128
Altered modulation of WNT-beta-catenin and PI3K/Akt pathways in IgA nephropathy 128
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 127
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 126
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 125
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 124
Dialysis-related systemic microinflammation is associated with specific genomic patterns 124
ALTERED ANTIGEN HANDLING AND INVOLVEMENT OF THE CX3CR1-FKN AXIS IN PROMOTING HEMATURIA IN IGA NEPHROPATHY PATIENTS 122
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 122
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 119
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 118
Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits 118
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 118
Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis 117
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 116
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 116
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 115
Safety and Efficacy of Citrate Anticoagulation for Continuous Renal Replacement Therapy for Acute Kidney Injury After Liver Transplantation: A Single-Center Experience. 115
Donor-transmitted cancer in kidney transplant recipients: a systematic review 115
Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study 115
Directional dominance on stature and cognition in diverse human populations. 114
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 113
mTOR Inhibition Role in Cellular Mechanisms 113
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 112
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease 112
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 112
INCIDENCE OF PRIMARY GLOMERULONEPHRITIS IN A LARGE NORTH-EASTERN ITALIAN AREA: A 13-YEAR RENAL BIOPSY STUDY 110
Mitochondria: a new therapeutic target in chronic kidney disease. 110
Assessment of physical performance and body composition in male renal transplant patients 110
Mantenimento del trapianto renale: impatto clinico a lungo termine di tre diversi protocolli immunosoppressivi Risultati di un ampio studio multicentrico italiano 110
Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders 110
How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network 109
T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function. 108
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 108
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 108
New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. 108
Late recovery of renal function in a patient with acute on chronic renal failure treated with peritoneal dialysis. 106
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 106
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 105
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 105
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 105
Alla ricerca di biomarker predittivi della ritardata ripresa funzionale del rene trapiantato: un utilizzo innovativo della genomica funzionale in trapiantologia. 104
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 104
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 103
Advantages of Using a Web-based Digital Platform for Kidney Preimplantation Biopsies 102
In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy. 101
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 100
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 100
Analysis of urinary exosomes applications for rare kidney disorders. 100
The Anti-Fibrotic Effect of Mycophenolic Acid-Induced Neutral Endopeptidase 100
Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment 99
Incidence of primary glomerulonephritis in a large North-Eastern Italian area: a 13-year renal biopsy study. 99
Predictive model for delayed graft function based on easily available pre-renal transplant variables 99
Aberrantly Methylated DNA Regions Lead to Low Activation of CD4+ T Cells in IgA Nephropathy. 99
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation. 99
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review. 99
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. 98
The UK10K project identifies rare variants in health and disease. 97
HFR aequilibrium can be an answer to malnutrition and hypotension in dialisys: case report 97
Tremor induced by Calcineurin inhibitor immunosuppression: a single-centre observational study in kidney transplanted patients 97
Impact of 3 Major Maintenance Immunosuppressive Protocols on Long-term Clinical Outcomes: Result of a Large Multicenter Italian Cohort Study Including 5635 Renal Transplant Recipients. 96
Compiti e funzioni dei Centri Interregionali Trapianto 94
Discovered cancers at postmortem donor examination: A starting point for quality improvement of donor assessment 93
The nephrologist of tomorrow: towards a kidney-omic future. 93
Heparanase: another renal player controlled by vitamin d. 92
Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. 90
Dialisi peritoneale: uno sguardo rivolto al futuro 89
Risk of Hospitalization and Death From COVID-19 Infection in Patients With Chronic Plaque Psoriasis Receiving a Biologic Treatment and Renal Transplant Recipients in Maintenance Immunosuppressive Treatment 89
Totale 12.312
Categoria #
all - tutte 61.251
article - articoli 56.547
book - libri 0
conference - conferenze 3.477
curatela - curatele 0
other - altro 449
patent - brevetti 0
selected - selezionate 0
volume - volumi 778
Totale 122.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021764 0 0 0 0 165 116 67 54 23 25 112 202
2021/20221.044 77 173 16 194 29 32 35 77 45 26 91 249
2022/20232.536 174 342 230 450 200 564 31 142 275 12 87 29
2023/20241.431 60 100 101 118 145 188 33 366 6 69 189 56
2024/20253.090 166 225 122 558 158 96 131 172 465 181 274 542
2025/20263.195 653 450 546 1.444 102 0 0 0 0 0 0 0
Totale 16.128